239 related articles for article (PubMed ID: 28748425)
1. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
Gianfrancesco MA; Schmajuk G; Haserodt S; Trupin L; Izadi Z; Jafri K; Shiboski S; Sirota M; Dudley RA; Yazdany J
Rheumatol Int; 2017 Oct; 37(10):1611-1618. PubMed ID: 28748425
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
[TBL] [Abstract][Full Text] [Related]
3. Sharp decline in hydroxychloroquine dosing-analysis of 17,797 initiators from 2007 to 2016.
Melles RB; Jorge AM; Marmor MF; Zhang Y; Choi HK
Clin Rheumatol; 2018 Jul; 37(7):1853-1859. PubMed ID: 29696437
[TBL] [Abstract][Full Text] [Related]
4. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
Kim JW; Kim YY; Lee H; Park SH; Kim SK; Choe JY
J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
[TBL] [Abstract][Full Text] [Related]
5. Adherence to Hydroxychloroquine Dosing Guidelines by Rheumatologists: An Electronic Medical Record-Based Study in an Integrated Health Care System.
Braslow RA; Shiloach M; Macsai MS
Ophthalmology; 2017 May; 124(5):604-608. PubMed ID: 28153440
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
Browning DJ; Yokogawa N; Greenberg PB; Perlman E
Am J Ophthalmol; 2020 Nov; 219():101-106. PubMed ID: 32610049
[TBL] [Abstract][Full Text] [Related]
7. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
[TBL] [Abstract][Full Text] [Related]
9. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
Takamasu E; Yokogawa N; Shimada K; Sugii S
Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
[TBL] [Abstract][Full Text] [Related]
10. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
Eo DR; Lee MG; Ham DI; Kang SW; Lee J; Cha HS; Koh E; Kim SJ
J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
[TBL] [Abstract][Full Text] [Related]
12. Improving Hydroxychloroquine Dosing and Toxicity Screening at a Tertiary Care Ambulatory Center: A Quality Improvement Initiative.
Koppikar S; Gottheil S; Farrer C; Gakhal N
J Rheumatol; 2021 Jan; 48(1):138-144. PubMed ID: 32238522
[TBL] [Abstract][Full Text] [Related]
13. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.
Chen CY; Wang FL; Lin CC
Clin Toxicol (Phila); 2006; 44(2):173-5. PubMed ID: 16615675
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
16. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.
Feldman CH; Collins J; Zhang Z; Subramanian SV; Solomon DH; Kawachi I; Costenbader KH
Semin Arthritis Rheum; 2018 Oct; 48(2):205-213. PubMed ID: 29458974
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
[TBL] [Abstract][Full Text] [Related]
19. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
Hosokawa Y; Oiwa H
Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
